BMY — Bristol-Myers Squibb Company Financial Health Analysis

Analyze Bristol-Myers Squibb Company's latest 10-K and 10-Q filings with AI. Get GAAP-grounded reports, red flag detection, fraud pattern matching against 206 SEC enforcement cases, and industry benchmarking. Free, no signup.

What PactDig Checks for BMY

• Revenue recognition compliance (ASC 606)
• Non-GAAP vs GAAP reconciliation
• Related-party transactions
• Goodwill & impairment risks
• Debt covenants & liquidity
• Insider trading patterns (Form 4)
• Historical fraud case similarity
• Industry benchmark comparison

Why Analyze BMY with PactDig?

Traditional financial analysis takes hours of manual work. PactDig's AI reads the entire SEC filing — every footnote, every MD&A section, every risk factor — and compares Bristol-Myers Squibb Company's financial patterns against 206 real SEC enforcement cases from the AAER database.

The fraud similarity score tells you whether BMY's financials resemble patterns seen in historical fraud cases like Enron, WorldCom, or Wirecard — before the market catches on.

How to Use

1. Click "Analyze Now" — no signup required
2. PactDig fetches BMY's latest 10-K/10-Q from SEC EDGAR
3. AI analyzes the filing in ~60 seconds
4. Get a detailed report with health score, red flags, and benchmarks

Backtest Report · Fraud Risk Leaderboard · All Companies